Viemed Healthcare, Inc.
VMD
$6.89
$0.385.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.97% | 22.54% | 26.22% | 31.75% | 32.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.97% | 22.54% | 26.22% | 31.75% | 32.79% |
| Cost of Revenue | 27.36% | 29.66% | 28.57% | 30.67% | 31.95% |
| Gross Profit | 15.26% | 18.11% | 24.73% | 32.44% | 33.33% |
| SG&A Expenses | 18.56% | 20.05% | 24.59% | 29.51% | 27.05% |
| Depreciation & Amortization | -9.58% | 6.61% | 31.39% | 53.74% | 54.29% |
| Other Operating Expenses | -1,704.65% | -641.84% | -219.27% | -81.73% | 89.98% |
| Total Operating Expenses | 21.55% | 23.44% | 25.68% | 29.39% | 29.02% |
| Operating Income | 2.25% | 12.69% | 32.70% | 65.12% | 97.15% |
| Income Before Tax | 22.20% | 12.36% | 15.83% | 34.51% | 70.50% |
| Income Tax Expenses | 24.73% | 14.78% | 21.22% | 48.53% | 65.02% |
| Earnings from Continuing Operations | 21.17% | 11.38% | 13.67% | 29.10% | 72.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.96% | 9.98% | 13.28% | 28.98% | 72.81% |
| EBIT | 2.25% | 12.69% | 32.70% | 65.12% | 97.15% |
| EBITDA | 6.79% | 14.66% | 26.62% | 44.27% | 56.78% |
| EPS Basic | 17.29% | 8.55% | 11.93% | 27.61% | 71.61% |
| Normalized Basic EPS | -12.03% | -1.72% | 14.49% | 42.91% | 81.68% |
| EPS Diluted | 22.49% | 14.58% | 10.09% | 18.90% | 64.95% |
| Normalized Diluted EPS | -12.13% | -1.81% | 14.69% | 42.72% | 79.35% |
| Average Basic Shares Outstanding | 1.41% | 1.32% | 1.29% | 1.14% | 0.52% |
| Average Diluted Shares Outstanding | 1.49% | 1.20% | 1.04% | 1.34% | 2.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |